{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:14:30Z","timestamp":1792480470640,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF-2022R1I1A3056585"],"award-info":[{"award-number":["NRF-2022R1I1A3056585"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF-2020R1A2C2005690"],"award-info":[{"award-number":["NRF-2020R1A2C2005690"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["RS-2023-00221356"],"award-info":[{"award-number":["RS-2023-00221356"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003716","name":"Korea Basic Science Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"publisher","award":["2024-1131-01"],"award-info":[{"award-number":["2024-1131-01"]}],"id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"publisher","award":["2024-1450"],"award-info":[{"award-number":["2024-1450"]}],"id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"publisher","award":["2021-2440"],"award-info":[{"award-number":["2021-2440"]}],"id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108647","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T19:37:55Z","timestamp":1748720275000},"page":"108647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development of 9-cinnamyl-9H-purine derivatives as potent anticancer agents through inactivation of NF-\u03bab\/p65 and p-STAT1 signaling pathways: Discovery of a new template for adenosine receptor"],"prefix":"10.1016","volume":"163","author":[{"given":"Linh","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeho","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadan","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bomi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Rae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Dong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Kook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Ae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyudong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2025.108647_bb0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd4010","article-title":"Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases","volume":"12","author":"Jordheim","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108647_bb0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.108647_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/978-3-540-89615-9_14","article-title":"Adenosine receptors and cancer","author":"Fishman","year":"2009","journal-title":"Adenosine Receptors in Health and Disease"},{"issue":"17","key":"10.1016\/j.bioorg.2025.108647_bb0020","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1158\/0008-5472.CAN-06-0365","article-title":"A1 adenosine receptors in microglia control glioblastoma-host interaction","volume":"66","author":"Synowitz","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108647_bb0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0026-895X(24)12875-1","article-title":"A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study","volume":"61","author":"Gessi","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"43","key":"10.1016\/j.bioorg.2025.108647_bb0030","doi-asserted-by":"crossref","first-page":"42121","DOI":"10.1074\/jbc.M301243200","article-title":"A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition","volume":"278","author":"Madi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108647_bb0035","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1158\/1078-0432.CCR-03-0651","article-title":"The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition","volume":"10","author":"Madi","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108647_bb0040","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/med.21456","article-title":"A3 adenosine receptors as modulators of inflammation: from medicinal chemistry to therapy","volume":"38","author":"Jacobson","year":"2018","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108647_bb0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4161\/cc.3.2.689","article-title":"HIF-1: a target for cancer, ischemia and inflammation\u2014too good to be true?","volume":"3","author":"Melillo","year":"2004","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108647_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcp.2006.03.020","article-title":"Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells","volume":"72","author":"Merighi","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108647_bb0055","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1593\/neo.05334","article-title":"A3 adenosine receptors modulate hypoxia-inducible factor-1a expression in human a375 melanoma cells","volume":"7","author":"Merighi","year":"2005","journal-title":"Neoplasia"},{"issue":"14","key":"10.1016\/j.bioorg.2025.108647_bb0060","first-page":"3181","article-title":"Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth","volume":"58","author":"Fishman","year":"1998","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108647_bb0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.neo.7900138","article-title":"Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists","volume":"3","author":"Bar-Yehuda","year":"2001","journal-title":"Neoplasia"},{"issue":"7\u20138","key":"10.1016\/j.bioorg.2025.108647_bb0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.drudis.2011.10.007","article-title":"Pharmacological and therapeutic effects of A3 adenosine receptor agonists","volume":"17","author":"Fishman","year":"2012","journal-title":"Drug Discov. Today"},{"issue":"14","key":"10.1016\/j.bioorg.2025.108647_bb0075","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/sj.onc.1207355","article-title":"An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3\u03b2 and NF-\u03baB","volume":"23","author":"Fishman","year":"2004","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108647_bb0080","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0959-8049(00)00130-1","article-title":"Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor","volume":"36","author":"Fishman","year":"2000","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108647_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/excr.2001.5327","article-title":"The A3 adenosine receptor as a new target for cancer therapy and chemoprotection","volume":"269","author":"Fishman","year":"2001","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108647_bb0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jcp.21863","article-title":"Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-\u03baB signalling pathway in thyroid cancer cells","volume":"221","author":"Morello","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108647_bb0095","doi-asserted-by":"crossref","first-page":"1132-IN5","DOI":"10.1593\/neo.09744","article-title":"Adenosine A3 receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity","volume":"11","author":"Jajoo","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.bioorg.2025.108647_bb0100","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00432-011-1031-z","article-title":"Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway","volume":"137","author":"Aghaei","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.108647_bb0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fimmu.2016.00109","article-title":"A metabolic immune checkpoint: adenosine in tumor microenvironment","volume":"7","author":"Ohta","year":"2016","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108647_bb0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/jm0255724","article-title":"3 \u2018-Aminoadenosine-5 \u2018-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptor","volume":"46","author":"Deninno","year":"2003","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108647_bb0115","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.bmcl.2008.01.070","article-title":"Structure-activity relationships of 2-chloro-N6-substituted-4\u2032-thioadenosine-5\u2019-N,N-dialkyluronamides as human A3 adenosine receptor antagonists","volume":"18","author":"Jeong","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108647_bb0120","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1021\/jm070259t","article-title":"Discovery of a new nucleoside template for human A3 adenosine receptor ligands: d-4 \u2018-thioadenosine derivatives without 4 \u2018-hydroxymethyl group as highly potent and selective antagonists","volume":"50","author":"Jeong","year":"2007","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2025.108647_bb0125","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1021\/jm960482i","article-title":"Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype","volume":"39","author":"Kim","year":"1996","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.108647_bb0130","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1021\/jm980094b","article-title":"Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes","volume":"41","author":"Kim","year":"1998","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108647_bb0135","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/jm000002u","article-title":"Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A3 receptor","volume":"43","author":"van Muijlwijk-Koezen","year":"2000","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108647_bb0140","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.108647_bb0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","article-title":"Cancer Chemopreventive activity of resveratrol, a natural product derived from grapes","volume":"275","author":"Meishiang Jang","year":"1997","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108647_bb0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jnutbio.2005.01.017","article-title":"Resveratrol as an anticancer nutrient: molecular basis, open questions and promises","volume":"16","author":"Signorelli","year":"2005","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108647_bb0155","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1530\/ERC-13-0171","article-title":"Resveratrol and cancer: focus on in vivo evidence","volume":"21","author":"Carter","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bioorg.2025.108647_bb0160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.lfs.2018.06.028","article-title":"Resveratrol: An overview of its anti-cancer mechanisms","volume":"207","author":"Elshaer","year":"2018","journal-title":"Life Sci."},{"issue":"1\/A","key":"10.1016\/j.bioorg.2025.108647_bb0165","first-page":"363","article-title":"Anticancer potential of curcumin: preclinical and clinical studies","volume":"23","author":"Aggarwal","year":"2003","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108647_bb0170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.17480\/psk.2020.64.5.343","article-title":"Review on the synthesis and biological activities of resveratrol and its derivatives","volume":"64","author":"Kim","year":"2020","journal-title":"Yakhak Hoeji"},{"issue":"7117","key":"10.1016\/j.bioorg.2025.108647_bb0175","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108647_bb0180","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0891-5849(00)00415-9","article-title":"Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein","volume":"29","author":"Schroeter","year":"2000","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108647_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027081","article-title":"Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108647_bb0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","article-title":"The therapeutic potential of resveratrol: a review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"NPJ precision oncology"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108647_bb0195","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/cb500086e","article-title":"Phytochemicals perturb membranes and promiscuously alter protein function","volume":"9","author":"Ingolfsson","year":"2014","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108647_bb0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/nyas.12879","article-title":"Resveratrol: challenges in analyzing its biological effects","volume":"1348","author":"Vang","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"18","key":"10.1016\/j.bioorg.2025.108647_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186619","article-title":"Obstacles against the Marketing of Curcumin as a drug","volume":"21","author":"Hassanzadeh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108647_bb0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/513481a","article-title":"Chemical con artists foil drug discovery","volume":"513","author":"Baell","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108647_bb0215","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108647_bb0220","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1021\/acs.jmedchem.7b00229","article-title":"The ecstasy and agony of assay interference compounds","volume":"60","author":"Aldrich","year":"2017","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108647_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acschembio.7b00903","article-title":"Seven year itch: Pan-assay interference compounds (PAINS) in 2017-utility and limitations","volume":"13","author":"Baell","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108647_bb0230","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The essential medicinal chemistry of curcumin","volume":"60","author":"Nelson","year":"2017","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108647_bb0235","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/ijc.24967","article-title":"The dark side of curcumin","volume":"126","author":"Burgos-Mor\u00f3n","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108647_bb0240","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/acs.jmedchem.6b00788","article-title":"Covalent modifiers: a chemical perspective on the reactivity of alpha,beta-unsaturated carbonyls with thiols via hetero-michael addition reactions","volume":"60","author":"Jackson","year":"2017","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108647_bb0245","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1021\/acsmedchemlett.3c00437","article-title":"Synthesis of 9-Cinnamyl-9H-purine derivatives as novel TLR4\/MyD88\/NF-kappaB pathway inhibitors for anti-inflammatory effects","volume":"14","author":"Pham","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108647_bb0250","doi-asserted-by":"crossref","first-page":"1051525","DOI":"10.3389\/fchem.2022.1051525","article-title":"Nucleobase-modified nucleosides and nucleotides: applications in biochemistry, synthetic biology, and drug discovery","volume":"10","author":"Berdis","year":"2022","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108647_bb0255","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108647_bb0260","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1172\/JCI26322","article-title":"IKK\/NF-\u03baB signaling: balancing life and death\u2013a new approach to cancer therapy","volume":"115","author":"Luo","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108647_bb0265","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-\u03baB: linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108647_bb0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","article-title":"Integrating cell-signalling pathways with NF-\u03baB and IKK function","volume":"8","author":"Perkins","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108647_bb0275","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1021\/acs.joc.0c02845","article-title":"Nucleophilic fluorination of heteroaryl chlorides and aryl triflates enabled by cooperative catalysis","volume":"86","author":"Hong","year":"2021","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108647_bb0280","article-title":"The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2025.108647_bb0285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cyto.2015.11.011","article-title":"The good and the bad faces of STAT1 in solid tumours","volume":"89","author":"Meissl","year":"2017","journal-title":"Cytokine"},{"issue":"130","key":"10.1016\/j.bioorg.2025.108647_bb0290","first-page":"19","article-title":"STAT1 in cancer: friend or foe?","volume":"24","author":"Zhang","year":"2017","journal-title":"Discov. Med."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108647_bb0295","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1246\/bcsj.40.2380","article-title":"Preparation of esters of carboxylic and phosphoric acid via quaternary phosphonium salts","volume":"40","author":"Mitsunobu","year":"1967","journal-title":"Bull. Chem. Soc. Jpn."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108647_bb0300","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1021\/cr800278z","article-title":"Mitsunobu and related reactions: advances and applications","volume":"109","author":"Swamy","year":"2009","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108647_bb0305","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/acsmedchemlett.2c00159","article-title":"Design, synthesis, and biological activity of l-1\u2032-homologated adenosine derivatives","volume":"13","author":"Nguyen","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"issue":"39","key":"10.1016\/j.bioorg.2025.108647_bb0310","doi-asserted-by":"crossref","first-page":"36361","DOI":"10.1021\/acsomega.3c05029","article-title":"Design and synthesis of l-1\u2019-homologated adenosine derivatives as potential anti-inflammatory agents","volume":"8","author":"Nguyen","year":"2023","journal-title":"ACS Omega"},{"issue":"19","key":"10.1016\/j.bioorg.2025.108647_bb0315","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1021\/ja01552a080","article-title":"A new synthesis of cyclopropanes from olefins","volume":"80","author":"Simmons","year":"1958","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108647_bb0320","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1021\/cr010007e","article-title":"Stereoselective cyclopropanation reactions","volume":"103","author":"Lebel","year":"2003","journal-title":"Chem. Rev."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108647_bb0325","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1021\/acs.jmedchem.6b00472","article-title":"The \u201cCyclopropyl fragment\u201d is a versatile player that frequently appears in preclinical\/clinical drug molecules","volume":"59","author":"Talele","year":"2016","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2025.108647_bb0330","doi-asserted-by":"crossref","first-page":"16012","DOI":"10.1021\/acs.jmedchem.0c01874","article-title":"Discovery and structure-activity relationships of novel template, truncated 1\u2019-homologated adenosine derivatives as pure dual PPARgamma\/delta modulators","volume":"63","author":"An","year":"2020","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108647_bb0335","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1021\/acs.joc.7b03174","article-title":"Transfer hydrogenation of aldehydes and ketones with isopropanol under neutral conditions catalyzed by a metal-ligand bifunctional catalyst [Cp*Ir(2,2\u2019-bpyO)(H(2)O)]","volume":"83","author":"Wang","year":"2018","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108647_bb0340","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejmech.2017.12.090","article-title":"Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections","volume":"145","author":"Wei","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108647_bb0345","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1039\/C9OB00209J","article-title":"Palladium-catalyzed allylic C-H oxidation under simple operation and mild conditions","volume":"17","author":"Guo","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108647_bb0350","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2147\/OTT.S161109","article-title":"Role of the NF\u03baB-signaling pathway in cancer","author":"Xia","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bioorg.2025.108647_bb0355","doi-asserted-by":"crossref","unstructured":"S. Banskota, J. Gautam, S.C. Regmi, P. Gurung, M.-H. Park, S.J. Kim, T.-g. Nam, B.-S. Jeong, J.-A. Kim, BJ-1108, a 6-Amino-2, 4, 5-Trimethylpyridin-3-ol analog, inhibits serotonin-induced angiogenesis and tumor growth through PI3K\/NOX pathway, PLoS One 11(1) (2016) e0148133.","DOI":"10.1371\/journal.pone.0148133"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108647_bb0360","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1538-7836.2003.00025.x","article-title":"Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen","volume":"1","author":"Colman","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108647_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.08305FP","article-title":"Troglitazone Inhibits Vascular Endothelial Growth Factor\u2013Induced Angiogenic Signaling via Suppression of Reactive Oxygen Species Production and Extracellular Signal\u2013Regulated Kinase Phosphorylation in Endothelial Cells","volume":"111","author":"Park","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2025.108647_bb0370","doi-asserted-by":"crossref","unstructured":"H. Lee, S. Banskota, D.-G. Kim, J.-H. Been, Y.-J. Jin, J. Gautam, H. Jang, T.-g. Nam, J.-A. Kim, B.-S. Jeong, Synthesis and antiangiogenic activity of 6-amido-2, 4, 5-trimethylpyridin-3-ols, Bioorg. Med. Chem. Lett. 24(14) (2014) 3131\u20133136.","DOI":"10.1016\/j.bmcl.2014.05.005"},{"key":"10.1016\/j.bioorg.2025.108647_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104805","article-title":"Synthesis and anticancer evaluation of 6-azacyclonol-2, 4, 6-trimethylpyridin-3-ol derivatives: M3 muscarinic acetylcholine receptor-mediated anticancer activity of a cyclohexyl derivative in androgen-refractory prostate cancer","volume":"110","author":"Karmacharya","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108647_bb0380","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41388-021-02090-z","article-title":"Cancer biology and molecular genetics of A3 adenosine receptor","volume":"41","author":"Mazziotta","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108647_bb0385","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1038\/s41467-024-47207-6","article-title":"Cryo-EM structures of adenosine receptor A3AR bound to selective agonists","volume":"15","author":"Cai","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108647_bb0390","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/acs.jctc.1c00136","article-title":"Reliable and accurate solution to the induced fit docking problem for protein\u2013ligand binding","volume":"17","author":"Miller","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108647_bb0395","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108647_bb0400","doi-asserted-by":"crossref","unstructured":"Z.-g. Gao, K.A. Jacobson, 2-Chloro-N6-cyclopentyladenosine, adenosine A1 receptor agonist, antagonizes the adenosine A3 receptor, Eur. J. Pharmacol. 443(1\u20133) (2002) 39\u201342.","DOI":"10.1016\/S0014-2999(02)01552-2"},{"key":"10.1016\/j.bioorg.2025.108647_bb0405","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12185-018-2422-6","article-title":"Characteristics and outcome of chronic myeloid leukemia patients with E255K\/V BCR\u2013ABL kinase domain mutations","volume":"107","author":"Naqvi","year":"2018","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bioorg.2025.108647_bb0410","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108647_bb0415","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction, proteins: structure","volume":"55","author":"Jacobson","year":"2004","journal-title":"Function, and Bioinformatics"},{"key":"10.1016\/j.bioorg.2025.108647_bb0420","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK a prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:51:40Z","timestamp":1776919900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825005279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":84,"alternative-id":["S0045206825005279"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108647","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of 9-cinnamyl-9H-purine derivatives as potent anticancer agents through inactivation of NF-\u03bab\/p65 and p-STAT1 signaling pathways: Discovery of a new template for adenosine receptor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108647"}}